Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
134.2 USD | +0.71% |
|
-7.44% | +35.17% |
06-14 | FDA asks COVID vaccine makers to target KP.2 strain with updated shots | RE |
06-13 | Moderna: successful trial for new Covid vaccine | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.17% | 51.07B | |
-7.47% | 38.78B | |
+35.88% | 38.61B | |
-10.62% | 27.32B | |
+12.24% | 26.35B | |
-18.27% | 19.46B | |
+41.17% | 13.58B | |
+29.73% | 12.46B | |
-3.14% | 11.75B | |
-11.51% | 10.81B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna : Goldman Sachs Adjusts Moderna's Price Target to $171 From $139, Maintains Buy Rating